Vaccine in Development for Early-Stage Breast Cancer
Researchers at the Moffitt Cancer Center are developing a new vaccine that will help early-stage breast cancer patients who have HER2 positive disease.
Study Shows Frog Slime Can Kill Flu Viruses
Researchers have identified a peptide in the mucus secreted by a South Indian frog that can kill certain types of flu viruses.
Study Finds Blood Plasma Can Restore Brain Function
Results from a new study show that brain function can be restored by human blood plasma.
Type 2 Diabetes Patients Have Higher Prevalence of Chronic Hepatitis B
A study has found that patients with type 2 diabetes have a higher prevalence of chronic hepatitis B virus infection.
Hemophilia B Gene Therapy Is Effective Despite Immune Reactions
A PhaseI/II study of nine patients with hemophilia B who underwent Spark Therapeutics’ SPK-9001 gene therapy are promising, despite two adverse autoimmune reactions.
Study Shows High Prevalence of Anti-TSH Receptor Antibody in Fibromyalgia
A study has found that patients with fibromyalgia have a high prevalence of anti-thyroid-stimulating hormone receptor antibody.
C.Diff Vaccine Shows Promise in Phase II Trial
Results of a Phase II clinical trial ofPfizer’s preventive vaccine againstClostridium difficile (C. diff) showed the vaccine was safe and stimulated a C. diff targeted immune response.
IVIG Treatment May Lead to Poorer Outcomes in GBS Patients
A new study shows that individuals treated with intravenous immune globulin (IVIG) for Guillain-Barré syndrome are at increased risk of developing hypoalbuminemia (reduced albumin levels).
Alzheimer’s Could Be Detected Seven Years Prior to Symptoms
A new study shows that brains of people genetically inclined toward Alzheimer’s are likely to show abnormal immune reactions as early as seven years before the expected onset of the disease.
Ebola Symptoms Absent in Some Infected Persons
A recent study shows that people can be infected with the Ebola virus and not show any symptoms.